Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial is a research paper published in Nature Medicine (2025). On theSindex it has a DataRank of 0.372. It has been cited 9 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.0262
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK116935
National Institutes of Health
Grant: 5K23DK116935-03
Improving Weight Loss in Early Non-responders to Behavioral Treatment
FWCI
7.65
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords